Intrinsiqs

Is Relay Therapeutics, Inc. overvalued?

Relay Therapeutics, Inc. (RLAY) — key valuation metrics and fundamentals.

No verdict
Price
$17.47
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$3.83B
Dividend yield
0.0%
Return on equity
-42.3%
Sector
Healthcare

See the full interactive analysis →

Fair value compares RLAY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.